ScholarIQanswers from OpenAlex

Low starting-dosage of nintedanib for the reduction of early termination

PaperCitations, authors & open-access status

Low starting-dosage of nintedanib for the reduction of early termination is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Low starting-dosage of nintedanib for the reduction of early termination have?

ScholarIQcitation count

Low starting-dosage of nintedanib for the reduction of early termination has 18 citations in the OpenAlex counts ScholarIQ stores.

When was Low starting-dosage of nintedanib for the reduction of early termination published?

ScholarIQyear

Low starting-dosage of nintedanib for the reduction of early termination has 2019 year in the ScholarIQ index.

What is the open-access status of Low starting-dosage of nintedanib for the reduction of early termination?

ScholarIQoa status

Low starting-dosage of nintedanib for the reduction of early termination has closed oa status in the ScholarIQ index.

What is the DOI of Low starting-dosage of nintedanib for the reduction of early termination?

ScholarIQdoi

The DOI for Low starting-dosage of nintedanib for the reduction of early termination is on the source record.

What is the PMID of Low starting-dosage of nintedanib for the reduction of early termination?

ScholarIQpmid

The PMID for Low starting-dosage of nintedanib for the reduction of early termination is on the source record.

What is the OpenAlex record for Low starting-dosage of nintedanib for the reduction of early termination?

ScholarIQopenalex

The OpenAlex for Low starting-dosage of nintedanib for the reduction of early termination is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial